What is Desjardins’ Forecast for Centric Health Q3 Earnings?

Centric Health Corp. (TSE:CRXFree Report) – Stock analysts at Desjardins issued their Q3 2024 EPS estimates for shares of Centric Health in a research note issued to investors on Wednesday, October 30th. Desjardins analyst G. Ho forecasts that the company will post earnings per share of $0.00 for the quarter.

Centric Health (TSE:CRXGet Free Report) last posted its earnings results on Thursday, August 8th. The company reported C($0.02) EPS for the quarter, missing analysts’ consensus estimates of C($0.01) by C($0.01). The business had revenue of C$91.97 million for the quarter, compared to analyst estimates of C$91.10 million.

A number of other research firms also recently issued reports on CRX. Ventum Cap Mkts upgraded Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th. Stifel Canada lowered shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.

Check Out Our Latest Stock Report on Centric Health

Centric Health Stock Performance

Featured Articles

Earnings History and Estimates for Centric Health (TSE:CRX)

Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.